Cogent Biosciences raises ~$162M in underwritten public offering of common stock and pre-funded warrants

Cogent Biosciences, Inc.

Offering of 15,169,698 shares at $8.25 per share plus pre-funded warrants for 3,030,302 shares at $8.24.
Underwriters exercised option to purchase an additional 2,730,000 shares on same terms.
Gross proceeds of approximately $162 million before underwriting discounts and expenses.
Pre-funded warrants exercisable immediately; holder cannot exceed 9.99% beneficial ownership without notice.
Offering made under effective shelf registration statement filed May 24, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.